Roche has posted a mixed set of data from two clinical trials of its anti-IL-33/ST2 antibody astegolimab in chronic obstructive pulmonary disease (COPD), casting a shadow over the programme. On the ...

AstraZeneca's hopes of a big new indication for respiratory drug Fasenra in chronic obstructive pulmonary disease (COPD) have been dashed by a negative phase 3 trial. The RESOLUTE study of IL-5 ...

Among adolescents, the presentation of obstructive sleep apnea syndrome (OSAS) mirrors many typical signs of a much more common age-related diagnosis ...

After another swing and a miss for AstraZeneca's Fasenra in chronic obstructive pulmonary disease (COPD), the company is pivoting to other options in its portfolio that might have potential to treat ...

Researchers conducted a prospective randomized controlled trial in 74 patients with stage III-IV COPD and prior hospitalization to assess the safety and efficacy of using telemedicine for follow-up.

My husband is considering contesting his brother’s will. Around 30 days before passing, his brother changed everything to go to a friend. He was in and out of the hospital the last few months of his ...

Guam Regional Medical City will be hosting this Saturday a free outreach aimed at raising awareness about lung health, including asthma, chronic obstructive pulmonary disease, COPD, and other ...

Novel anti-ST2 monoclonal antibody astegolimab modestly reduced chronic obstructive pulmonary disease (COPD) exacerbations in the phase IIb ALIENTO trial. The biologic dosed every 2 weeks reduced ...

When you feel like you can't breathe deeply enough, can't get enough air, or are working too hard to breathe, you have shortness of breath. Doctors sometimes call it dyspnea. Shortness of breath can ...

SEATTLE and VANCOUVER, British Columbia, Sept. 22, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development ...

Clear visuals can make complicated ideas easier to understand, and Microsoft Visio Professional 2024 is designed to help you create them. Right now, you can get a lifetime license for Windows for ...